Brief: Adial Pharmaceuticals Reports Third Quarter 2022 Financial Results And Provides Business Update
Nov 14 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* ADIAL PHARMACEUTICALS INC - NET LOSS PER SHARE FOR Q3 OF
2022
WAS $0.12
Source text for Eikon: ID:nGNX3ZBcbp
Further company coverage: ADIL.O
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)